Oct 4 Flashcards

1
Q

Describe Selection Bias in RCTs

A
  • with respect to randomization; if we don’t adequately generate the random sequences (can have runs; if you’re making a random sequence of 10 sometimes it might end up that you have 9 assigned to A and 1 assigned to B so you get a run of people entering your study getting assigned to A- if they are early morning people, different reponse to people, etc. this could bring in selection bias)
  • allocation concealment; we don’t know who is assigned to what until the moment they are assigned (compromisation in this process ie. research assistant administering therapy- if they know what the next assignment is and you think the next person is going to do really well on this treatment you might give it but if you think the next person won’t do well on this treatment you might say oh let’s just give it to the next person
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe Performance Bias in RCTs

A
  • differences that occur due to knowledge of intervention allocation in either the resercher or the participant
  • results in differences in the care received by the intervention and control groups in a trial that are over and above the intervention that are being compared
  • performance bias: whether or not we’ve done a good job of blinding
  • if blinding has been done properly, this usually means we have taken care of performance bias so not an issue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is attrition bias in RCTs

A
  • also in prospective cohort studies
  • incomplete outcome data/losses to follow up
  • anytime you have lots of people dropping out, it compromises your ability to say something about the treatment
  • this becomes more important when the drop out is differential (one group has higher dropout rate than others. if that is related to treatment or outcomes, that is a problem)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is detection bias in RCTs

A
  • similar to performance bias except this is the way we report events
  • want know the people assessing the outcome- are they biased about deciding who is a case/control, who has developed outcome/hasn’t
  • if we know the treatment someone was assigned to, you might be more likely to say one over the other
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What bias are case control studies more susceptible to than other studies?

A
  • recall bias
  • we select people once they are already a case and ask them to remember exposure histories
  • if exposure histories happened a long time ago they may be recalled differently in cases than controls
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is a common bias seen in cohort studies?

A
  • selection bias because there could be different rates of loss to follow up in the exposed and unexposed groups
  • whatever factors that lead people to be exposed may lead them to not be good at participating in studies (or vice versa)
  • people that stay in study and tend to be interested in their health are different than people who do not
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe random error

A

-reduces precision of the estimates (OR, RR, etc.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe systematic error

A
  • more of an issue of getting the wrong answer
  • reduces validity or accuracy of the estimates
  • eg. scale routinely weighing people 10lbs less than they really are
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Fill in the blanks

A

Figure A: Accurate and precise, no error (can do a number of studies and each study gets close to the truth)

Figure B: precise, but not accurate. Systematic error. Lots of studies cluster in the same area (precise) but they are far from the truth. All studies are misestimating truth by about the same amount.

Figure C: Accurate, but not precise. Random error. Number of studies all aren’t going to get same answer due to random variability in populations they study, outcomes they assess, but dots are more spread out than in Figure A where everything was true.

Figure D: Neither accurate nor precise. Systematic and random error. All studies get wrong answers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is internal validity?

A
  • we do a study and it measures what we intend it to measure
  • gives unbiased estimate of true effect in that study
  • study was designed properly, used the best methods, collected data in best way we could, analysis was high quality
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is external validity?

A
  • refers to generalization
  • could get a specific population and do a well controlled study but all of the people that contribute to that study might not be representative of the entire population
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is confounding?

A
  • refers to the “mixing” of the effect of the exposure with the effect of another factor (the confounder)
  • distorts the estimated measure of association
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is a confounder?

A
  • a variable that is: a risk factor for the disease of interest (independent of exposure), associated with the exposure of interest (without being a consequence of the exposure)
  • not in the causal pathway

exposure variable –> variable in causal pathway (happens as the result of an exposure that then leads to disease) –> diesease variable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Is persistent coughing a confounder with smoking and SUI?

A
  • first criterion satisfied: coughing causes an increase in intra-abdominal pressure which leads to SUI (risk factor)
  • any coughing may lead to SUI regardless of smoking status
  • however, smoking increases frequency/intensity of coughing so smokers may have more bouts of SUI but it’s happening because coughing is the mechanism by which smoking affects SUI
  • smoking –> coughing –> SUI (in causal pathway) therfore is not a confounder
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What studies to confounders affect?

A
  • all observational study designs
  • without randomization, there is no way to be certain that possible confounders are distributed evenly across the groups
  • uneven distribution of confounders causes biased ORs and RRs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What stages can we handle confounding at?

A

-design or analysis

17
Q

What is the best way to control confounding?

A
  • randomization with RCT
  • balances known and unknown confounders
  • can’t always randomize in observational study because we don’t do anything to people we just watch
18
Q

What is restriction?

A
  • limit entrance of participants into people that fall into one category of the other of the confounder
  • reduces available participants
  • if we don’t actually know association between the confounder and the outcome, we may not be able to choose the correct cut off point between categories of confounders (if it’s improperly defined can lead to residual confounding)
19
Q

What is matching?

A
  • way to handle confounding
  • only include controls with comparable characteristics to cases on more than one or one variable
  • problems: time consuming and costly to find comparison controls, cannot evaluate effects of matched variables on disease
20
Q

What is multivariable regression analysis?

A
  • look at associations and add confounding variables to association models to help adjust for different confounders
  • if you’ve measured confounder properly in study, you can deal with it in the analysis phase
21
Q

What is stratification?

A
  • separate ORs or RRs by different levels of a confounder
  • take weighted averages of each stratum to make sure we get overall effect
  • can become difficult with many stratum (many confounders)
  • cannot be done when the confounder is a continuous variable that cannot be categorized (eg. age or BP- decide not to put people in groups)
22
Q

How do we identify confounders?

A
  • literature search is important (when we read previous studies, gives guidance as to which potential confounders to collect data on)
  • biological plausability (this always changes, not all confounders known, results unknowingly biased- things that we thought were confounders have been proven wrong)
23
Q

What can a confounder do?

A

-wipe out an association, create an invalid association, reverse the direction of an association, change the degree of association

24
Q

What is effect modification?

A
  • tells us the effect of the primary exposure on outcome differs depending on the level of a third variable
  • biological phenomenon
  • think effect of exposure on outcome differs according to some factor
  • confounding is a bias such that we get the wrong answer, effect modification shows exposure has different impact in different circumstances
  • when the magnitude of the effect of the primary exposure on an outcome (association) differs depending on the level of a third variable
25
Q

How do you design 2x2 tables in case control versus cohort study

A
  • in case control, you are looking at outcomes then going back and assessing exposure
  • try to put outcome on the y axis then exposure on the x axis
  • if we do cohort study starting with exposure then looking for outcome, exposure on y axis and outcome on x axis
26
Q

What are stratified analyses?

A
  • stratum specific estimates
  • take weighted average
  • controlled for the confounder
  • Mantel Haenszel Estimator= measure average effect of exposure across all strata (accounts for confounding and EM)
  • when we have confounding, crude odds ratio doesn’t match any stratum specific estimates
27
Q

How do you tell if there is a confounder versus EM with MH estimator?

A
  • if MH estimator is equal to 1 or less than crude odds ratio and within each stratum odds ratio is also 1 we would say we have developed a confounder
  • if MH and crude odds ratio are identical but we have different stratum specific odds ratios then we have EM
28
Q

Can something be both a confounder and effect modifier? Give an example.

A
  • yes
  • age is classic example
  • for all diseases, age is a risk factor
  • second, the effect of an exposure of disease differs between young and old people often
  • eg: think of the effect of a fall on a 4 year old versus a 94 year old. In both cases, age is associated with increased risk of falls and the probability of a bad outcome of fallse. Age also impacts how serious the consequences of the fall will be. So same exposure (fall) will have different result based on age.
29
Q

In a scenario of both confounding and effect modification, some of the observed effect of an exposure on an outcome is due to….

A

the confounding effect of the third variable, but this effect is not completely eliminated within each stratum

-Mantel Haenszel average of stratum specific estimates is somewhere between stratum specific ORs and less than the crude OR

30
Q

In effect modification, the observed effect of an exposure on an outcome depends on…

A

the level of the effect-modifying variable

-Mantel Haenszel average of stratum specific estimates is somewhere between the stratum specific OR and equal to the crude OR

31
Q

In pure confounding, _______ of an exposure on an outcome are due to ______

A

In pure confounding, all of the observed effect of an exposure on an outcome are due to the confounding variable

-OR=1.00

32
Q

In a scenario in which the third variable is neither a confounder nor an effect modifier, the association is ____

A

the same no matter how we look at it!

  • stratum specific estimates are equal
  • Mantel Haenszel average of stratum specific estimates is equal to the stratum specific odds ratios and equal to the crude OR (but it’s not 1)